Inventiva (IVA) Shares Outstanding (Weighted Average) (2018 - 2025)

Inventiva (IVA) recorded quarterly Shares Outstanding (Weighted Average) of $2.2 million in Q4 2025, down 99.63% quarter-over-quarter from $602.2 million in Q2 2025, and up 119.91% on a YoY basis from $1.0 million in Q4 2024.

Inventiva (IVA) Shares Outstanding (Weighted Average) (2018 - 2025) Analysis & Trends

Inventiva's Shares Outstanding (Weighted Average) history runs 8 years deep, the most recent figure standing at $2.2 million for Q4 2025.

  • In Q4 2025, Shares Outstanding (Weighted Average) rose 119.91% year-over-year to $2.2 million; the TTM figure through Dec 2025 stood at $2.2 million (up 119.91% YoY), while the FY2025 annual figure was $2.2 million, up 119.91% from the prior year.
  • Shares Outstanding (Weighted Average) was $2.2 million for Q4 2025 at Inventiva, down from $602.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $836.0 million in Q2 2024 to a low of $768.28 in Q2 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $187.2 million across 5 years, with a median of $43.0 million in 2022.
  • Biggest YoY gain for Shares Outstanding (Weighted Average) was 58606886.66% in 2024; the steepest drop was 98.18% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $46.8 million in 2021, then decreased by 8.06% to $43.0 million in 2022, then soared by 30.44% to $56.1 million in 2023, then plunged by 98.18% to $1.0 million in 2024, then surged by 119.91% to $2.2 million in 2025.
  • The last three Shares Outstanding (Weighted Average) figures came in at $2.2 million (Q4 2025), $602.2 million (Q2 2025), and $1.0 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - 185,491.37 Bn
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 4,489.46 Bn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 100.00 Bn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 118.76 Bn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - 417.01 Bn
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 254.10 Mn
9 Abivax 95.45 Bn 95.45 Bn - 928.40 Mn
10 Inventiva 8.93 Mn -259.80 Mn - 2.25 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.25 Mn
Jun 30, 2025 602.20 Mn
Dec 31, 2024 1.02 Mn
Jun 30, 2024 836.02 Mn
Dec 31, 2023 56.07 Mn
Oct 11, 2023 6.37 Mn
Jun 30, 2023 1,426.49
Dec 31, 2022 42.99 Mn
Jun 30, 2022 768.28
Dec 31, 2021 46.76 Mn
Mar 31, 2021 465.61 Mn
Dec 31, 2020 46.06 Mn
Dec 31, 2019 29.72 Mn
Dec 31, 2018 25.40 Mn